Table 3. Technical and quality results.
n = 37 | |
Technical success rate | 92 % (34 patients) |
Median number of inserted markers (per patient) | 3 (0–4) |
Adverse events (%) | 8 % |
Fever | 2.7 % |
Mild acute pancreatitis | 2.7 % |
Biliary stent migration | 2.7 % |
n = 34 | |
SBRT delivered (%) | 97.1 % |
Markers migration rate (%) | 5.9 % (2 patients) |
n = 32 | |
Markers inside the tumor or < 1 cm | |
|
12.5 % |
|
31.3 % |
|
56.2 % |
Markers in the extremity of the tumor | |
|
25 % |
|
68.8 % |
|
12.5 % |
Markers in different planes | |
|
56.3 % |
|
43.7 % |
Distance from the biliary stent > 1 mm | |
|
15.6 % |
|
84.4 % |
Overlap FEV | |
|
71.9 % |
|
28.1 % |
(n) = Points attributed accordingly to the quality score.